Multiple myeloma: family history and mortality in second primary cancers.
作者信息
Chattopadhyay Subhayan, Yu Hongyao, Sud Amit, Sundquist Jan, Försti Asta, Hemminki Akseli, Hemminki Kari
机构信息
Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany.
Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.
出版信息
Blood Cancer J. 2018 Aug 7;8(8):75. doi: 10.1038/s41408-018-0108-1.
Abstract
摘要
相似文献
1
Multiple myeloma: family history and mortality in second primary cancers.
Blood Cancer J. 2018 Aug 7;8(8):75. doi: 10.1038/s41408-018-0108-1.
2
Extramedullary disease in multiple myeloma in the era of novel agents.
Br J Haematol. 2015 Jun;169(6):763-5. doi: 10.1111/bjh.13384. Epub 2015 Mar 30.
3
Occurrence of primary cancers in association with multiple myeloma and Kaposi's sarcoma in the United States, 1973-1995.
Int J Cancer. 2000 Feb 15;85(4):453-6. doi: 10.1002/(sici)1097-0215(20000215)85:4<453::aid-ijc1>3.0.co;2-l.
4
Multiple myeloma and its therapies: to what extent do they contribute to the increased incidence of second malignant neoplasms?
Curr Med Res Opin. 2012 Jul;28(7):1129-40. doi: 10.1185/03007995.2012.688800. Epub 2012 Jun 6.
5
Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
Haematologica. 2016 Apr;101(4):e145-8. doi: 10.3324/haematol.2015.134049. Epub 2015 Dec 17.
6
The Shreveport Myeloma Experience: Survival, Risk Factors and Other Malignancies in the Age of Stem Cell Transplantation.
Acta Haematol. 2016;135(3):146-55. doi: 10.1159/000440970. Epub 2015 Nov 21.
7
Multiple myeloma in association with second malignancy.
J BUON. 2013 Apr-Jun;18(2):448-52.
8
Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups.
Blood Cancer J. 2014 Sep 5;4(9):e243. doi: 10.1038/bcj.2014.63.
9
[The epidemiology of multiple myeloma].
Nihon Rinsho. 2015 Jan;73(1):7-12.
10
Connect MM® - the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide.
Leuk Lymphoma. 2016 Sep;57(9):2228-31. doi: 10.3109/10428194.2015.1132419. Epub 2016 Jan 13.
引用本文的文献
1
Global, regional, and national multiple myeloma burden from 1990 to 2021: a systematic analysis for of the Global Burden of Disease Study 2021.
BMC Public Health. 2025 Mar 19;25(1):1054. doi: 10.1186/s12889-025-22240-2.
2
The risk and survival of multiple myeloma as the second primary malignancy in a single Chinese center.
Transl Cancer Res. 2024 Jun 30;13(6):2905-2912. doi: 10.21037/tcr-23-2336. Epub 2024 Jun 11.
3
A Linear Relationship between the Number of Cancers among First-degree Relatives and the Risk of Multiple Primary Cancers.
Cancer Prev Res (Phila). 2024 Jun 13. doi: 10.1158/1940-6207.CAPR-24-0062.
4
Epidemiology, genetics and treatment of multiple myeloma and precursor diseases.
Int J Cancer. 2021 Dec 15;149(12):1980-1996. doi: 10.1002/ijc.33762. Epub 2021 Aug 30.
本文引用的文献
1
Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
J Clin Oncol. 2017 May 10;35(14):1584-1590. doi: 10.1200/JCO.2016.70.9709. Epub 2017 Mar 13.
2
Concordant and discordant familial cancer: Familial risks, proportions and population impact.
Int J Cancer. 2017 Apr 1;140(7):1510-1516. doi: 10.1002/ijc.30583. Epub 2017 Jan 20.
3
Second primary malignancies in multiple myeloma: an overview and IMWG consensus.
Ann Oncol. 2017 Feb 1;28(2):228-245. doi: 10.1093/annonc/mdw606.
4
Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries.
Sci Rep. 2016 Feb 24;6:22084. doi: 10.1038/srep22084.
5
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
N Engl J Med. 2015 Dec 24;373(26):2499-511. doi: 10.1056/NEJMoa1505949.
6
Search for familial clustering of multiple myeloma with any cancer.
Leukemia. 2016 Mar;30(3):627-32. doi: 10.1038/leu.2015.279. Epub 2015 Oct 9.
7
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.
Nat Rev Clin Oncol. 2013 May;10(5):289-301. doi: 10.1038/nrclinonc.2013.41. Epub 2013 Mar 26.
8
Second malignant neoplasms: assessment and strategies for risk reduction.
J Clin Oncol. 2012 Oct 20;30(30):3734-45. doi: 10.1200/JCO.2012.41.8681. Epub 2012 Sep 24.
9
Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
Int J Cancer. 2013 Feb 15;132(4):944-50. doi: 10.1002/ijc.27678. Epub 2012 Jul 21.
10
Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.
Int J Cancer. 2009 Nov 1;125(9):2147-50. doi: 10.1002/ijc.24514.
Zotero 插件